Medscape Conference Coverage, based on selected sessions at the:

American Society for Therapeutic Radiology and Oncology (ASTRO) 50th Annual Meeting

September 21 - 25, 2008; Boston, Massachusetts

This activity is not sanctioned by, nor a part of, the American Society for Therapeutic Radiology and Oncology. Conference news does not receive grant support and is produced independently.

Conference News

  • Proton Radiation and Risk for Secondary Cancers

    Specialized radiation therapy using protons appears to have a reduced risk of inducing secondary cancers, compared with standard photon radiation.
    Medscape Medical News, September 25, 2008
  • Hormone Therapy Before Brachytherapy

    In older men with prostate cancer, the use of hormone therapy before brachytherapy could increase the risk for mortality.
    Medscape Medical News, September 24, 2008
  • Long-Term Cancer Survivors and Severe Distress

    In people with cancer who survive 5 years or more, severe psychological distress occurs at nearly twice the rate as it does among people without cancer.
    Medscape Medical News, September 24, 2008
  • Initial Whole-Brain Radiation for Brain Metastases

    Radiation oncologists documenting the deleterious effects of whole-brain radiation on neurocognitive functioning question whether it should remain a standard initial therapy for brain metastases.
    Medscape Medical News, September 24, 2008
  • Cancer Patients Decline Clinical Trial Enrollment

    Cancer patients insured by Medicare's HMO plans might not be able to participate in cancer clinical trials because of prohibitive costs.
    Medscape Medical News, September 24, 2008
  • Shorter Radiation for Breast Cancer Effective

    Accelerated radiotherapy schedules, shortened to 3 weeks for whole-breast irradiation and to 1 week with balloon brachytherapy, appear to be as effective as standard radiotherapy, which can take 6 to 7 weeks.
    Medscape Medical News, September 23, 2008
Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Society for Therapeutic Radiology and Oncology. These materials and the related activity are not sanctioned by the American Society for Therapeutic Radiology and Oncology or the commercial supporter of the conference and do not constitute an official part of that conference.